• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A-I/II类清道夫受体和CD36是负责摄取修饰的低密度脂蛋白从而导致巨噬细胞脂质负荷的主要受体。

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

作者信息

Kunjathoor Vidya V, Febbraio Maria, Podrez Eugene A, Moore Kathryn J, Andersson Lorna, Koehn Stephanie, Rhee Jeongmi S, Silverstein Roy, Hoff Henry F, Freeman Mason W

机构信息

Lipid Metabolism Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

出版信息

J Biol Chem. 2002 Dec 20;277(51):49982-8. doi: 10.1074/jbc.M209649200. Epub 2002 Oct 9.

DOI:10.1074/jbc.M209649200
PMID:12376530
Abstract

Modification of low density lipoprotein (LDL) can result in the avid uptake of these lipoproteins via a family of macrophage transmembrane proteins referred to as scavenger receptors (SRs). The genetic inactivation of either of two SR family members, SR-A or CD36, has been shown previously to reduce oxidized LDL uptake in vitro and atherosclerotic lesions in mice. Several other SRs are reported to bind modified LDL, but their contribution to macrophage lipid accumulation is uncertain. We generated mice lacking both SR-A and CD36 to determine their combined impact on macrophage lipid uptake and to assess the contribution of other SRs to this process. We show that SR-A and CD36 account for 75-90% of degradation of LDL modified by acetylation or oxidation. Cholesteryl ester derived from modified lipoproteins fails to accumulate in macrophages taken from the double null mice, as assessed by histochemistry and gas chromatography-mass spectrometry. These results demonstrate that SR-A and CD36 are responsible for the preponderance of modified LDL uptake in macrophages and that other scavenger receptors do not compensate for their absence.

摘要

低密度脂蛋白(LDL)的修饰可导致这些脂蛋白通过一类被称为清道夫受体(SRs)的巨噬细胞跨膜蛋白被大量摄取。先前已表明,两种SR家族成员SR-A或CD36中的任何一种发生基因失活,均可在体外减少氧化LDL的摄取,并减少小鼠的动脉粥样硬化病变。据报道,其他几种SR也可结合修饰的LDL,但其对巨噬细胞脂质蓄积的作用尚不确定。我们培育出同时缺乏SR-A和CD36的小鼠,以确定它们对巨噬细胞脂质摄取的联合影响,并评估其他SR在这一过程中的作用。我们发现,SR-A和CD36占乙酰化或氧化修饰LDL降解的75%-90%。通过组织化学和气相色谱-质谱分析评估,来自修饰脂蛋白的胆固醇酯未能在双敲除小鼠的巨噬细胞中蓄积。这些结果表明,SR-A和CD36是巨噬细胞摄取修饰LDL的主要原因,且其他清道夫受体无法弥补它们的缺失。

相似文献

1
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.A-I/II类清道夫受体和CD36是负责摄取修饰的低密度脂蛋白从而导致巨噬细胞脂质负荷的主要受体。
J Biol Chem. 2002 Dec 20;277(51):49982-8. doi: 10.1074/jbc.M209649200. Epub 2002 Oct 9.
2
Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein.B类清道夫受体CD36和SR-BI是次氯酸盐修饰的低密度脂蛋白的受体。
J Biol Chem. 2003 Nov 28;278(48):47562-70. doi: 10.1074/jbc.M308428200. Epub 2003 Sep 10.
3
High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II.缺乏I/II型A类清道夫受体的小鼠巨噬细胞对氧化型低密度脂蛋白的高亲和力饱和摄取。
J Biol Chem. 1997 May 16;272(20):12938-44. doi: 10.1074/jbc.272.20.12938.
4
Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.天然和修饰的低密度脂蛋白可增加巨噬细胞B类清道夫受体CD36的功能性表达。
J Biol Chem. 1997 Aug 22;272(34):21654-9. doi: 10.1074/jbc.272.34.21654.
5
Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36.酶促降解的低密度脂蛋白优先结合CD14(高表达)CD16(阳性)单核细胞,并诱导泡沫细胞形成,这种诱导仅部分由B类清道夫受体CD36介导。
Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):1004-10. doi: 10.1161/01.atv.21.6.1004.
6
Scavenger receptors and oxidized low density lipoproteins.清道夫受体与氧化型低密度脂蛋白
Clin Chim Acta. 1999 Aug;286(1-2):191-205. doi: 10.1016/s0009-8981(99)00101-1.
7
Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.载脂蛋白E缺陷小鼠的低密度脂蛋白以CD36和A类清道夫受体依赖的方式诱导巨噬细胞脂质蓄积。
Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):168-73. doi: 10.1161/01.ATV.0000149145.00865.d9. Epub 2004 Oct 28.
8
Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages.α-生育酚可降低人单核细胞衍生巨噬细胞中CD36的表达。
J Lipid Res. 2001 Apr;42(4):521-7.
9
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.一类新的致动脉粥样硬化氧化磷脂通过清道夫受体CD36促进巨噬细胞泡沫细胞形成,并在动脉粥样硬化病变中富集。
J Biol Chem. 2002 Oct 11;277(41):38517-23. doi: 10.1074/jbc.M205924200. Epub 2002 Jul 26.
10
Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages.随着巨噬细胞向泡沫细胞的转变,CD36、CLA-1和CD68的表达协同增加,而SR-A和LOX-1的表达则不然。
J Atheroscler Thromb. 2002;9(1):57-64. doi: 10.5551/jat.9.57.

引用本文的文献

1
Macrophage-Targeted Nanomedicine for the Treatment of Atherosclerosis.用于治疗动脉粥样硬化的巨噬细胞靶向纳米药物
Int J Nanomedicine. 2025 Aug 25;20:10325-10352. doi: 10.2147/IJN.S529988. eCollection 2025.
2
Oxidized phospholipid damage signals as modulators of immunity.氧化磷脂损伤信号作为免疫调节剂
Open Biol. 2025 Jul;15(7):240391. doi: 10.1098/rsob.240391. Epub 2025 Jul 30.
3
The Effect of Kidney Transplantation and Immunosuppressive Therapy on Adipose Tissue Content and Adipocytokine Plasma Concentration-Preliminary Study.
肾移植及免疫抑制治疗对脂肪组织含量和血浆脂肪细胞因子浓度的影响——初步研究
Curr Issues Mol Biol. 2025 Apr 7;47(4):255. doi: 10.3390/cimb47040255.
4
Gut microbiota's role in heart failure.肠道微生物群在心力衰竭中的作用。
Heart Fail Rev. 2025 Jul 9. doi: 10.1007/s10741-025-10543-w.
5
The Role of Lysyl Oxidase in the Pathological Stage of Atherosclerosis: Structural Stabilizer or Disease Driver?赖氨酰氧化酶在动脉粥样硬化病理阶段的作用:结构稳定剂还是疾病驱动因素?
Curr Atheroscler Rep. 2025 Jul 5;27(1):69. doi: 10.1007/s11883-025-01312-z.
6
Macrophage Deficiency of Sorting Nexin 25 Suppress Plaque Formation in Atherosclerotic Lesions in Mice.分选连接蛋白25的巨噬细胞缺陷抑制小鼠动脉粥样硬化病变中的斑块形成。
Acta Histochem Cytochem. 2025 Apr 26;58(2):101-106. doi: 10.1267/ahc.24-00055. Epub 2025 Apr 12.
7
Foamy macrophages in atherosclerosis: unraveling the balance between pro- and anti-inflammatory roles in disease progression.动脉粥样硬化中的泡沫巨噬细胞:揭示疾病进展中促炎和抗炎作用之间的平衡
Front Cardiovasc Med. 2025 May 2;12:1589629. doi: 10.3389/fcvm.2025.1589629. eCollection 2025.
8
The Role of Ubiquitination on Macrophages in Cardiovascular Diseases and Targeted Treatment.泛素化在巨噬细胞在心血管疾病中的作用及靶向治疗
Int J Mol Sci. 2025 Apr 30;26(9):4260. doi: 10.3390/ijms26094260.
9
USP22 enhances atherosclerotic plaque stability and macrophage efferocytosis by stabilizing PPARγ.USP22通过稳定PPARγ来增强动脉粥样硬化斑块稳定性和巨噬细胞吞噬作用。
Commun Biol. 2025 Apr 29;8(1):678. doi: 10.1038/s42003-025-08116-6.
10
Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease.中药对冠心病中白细胞介素-17调节的巨噬细胞的调节作用。
Front Pharmacol. 2025 Apr 10;16:1499786. doi: 10.3389/fphar.2025.1499786. eCollection 2025.